Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
AAEV, affirmed, ameliorating, Amgen, antisense, ASO, cancer, characterization, chemistry, clearance, cohort, customary, deducting, delta, detected, dose, expedited, expertise, feedback, Highbridge, history, Horizon, Hosted, induce, injection, Investor, Kelliher, kidney, liver, lower, main, mice, Michael, moiety, MRI, neutralization, noncurrent, nonprofit, Notably, omicron, organization, ovarian, overcome, par, partially, predominant, presence, PRV, purification, reached, registered, revealed, scalable, siRNA, Society, spike, steady, StealthX, Summit, surface, webinar, WMS
Removed:
chain, enrolling
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view